Dendreon Corp (DNDN)

0.06
0.00 6.02
NASDAQ : Health Care
Prev Close 0.06
Open 0.06
Day Low/High 0.06 / 0.06
52 Wk Low/High 0.04 / 3.46
Volume 1.37M
Avg Volume 5.11M
Exchange NASDAQ
Shares Outstanding 158.72M
Market Cap 20.16M
EPS -1.95
P/E Ratio N/A
Div & Yield N.A. (N.A)
'Mad Money' Lightning Round: Bearish on Dendreon

'Mad Money' Lightning Round: Bearish on Dendreon

During the Lightning Round, Cramer says Dendreon is 'too speculative for this guy.'

Dendreon To Host Conference Call On May 7 To Announce First Quarter Financial Results And Webcast Presentations At Upcoming Conferences

Dendreon To Host Conference Call On May 7 To Announce First Quarter Financial Results And Webcast Presentations At Upcoming Conferences

April 9, 2012--Dendreon Corporation (Nasdaq:DNDN) today announced that management will host a conference call on Monday, May 7, 2012, at 4:30 p.

5 Stocks Setting Up to Break Out

5 Stocks Setting Up to Break Out

These stocks look poised to break out and trade higher from current levels.

7 Cancer Drug Stocks to Know Right Now

7 Cancer Drug Stocks to Know Right Now

A first look at the cancer drug stocks that could run up in value as we get closer to the big ASCO conference.

J&J Prostate Cancer Drug Scores Big Win, Hurts Dendreon, Helps Medivation

J&J Prostate Cancer Drug Scores Big Win, Hurts Dendreon, Helps Medivation

Positive results from a trial of J&J's Zytiga promise to once again shift the prostate cancer drug field.

Dendreon Stock Gaps Down On Today's Open (DNDN)

Dendreon Stock Gaps Down On Today's Open (DNDN)

Shares of Dendreon (Nasdaq:DNDN) were gapping down Thursday morning with an open price 13.5% lower than Wednesday's closing price. The stock closed at $10.87 yesterday and opened today's trading at $9.40.

Dendreon Announces Webcast Presentation At Upcoming Conferences

Dendreon Announces Webcast Presentation At Upcoming Conferences

March 5, 2012--Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the following conferences: Cowen and Company 32nd Annual Health Care Conference in Boston, MA, on ...

Wednesday's Top 10 Articles, Videos on TheStreet

Wednesday's Top 10 Articles, Videos on TheStreet

These stories made today's top 10 list of articles and videos on TheStreet.

Biotech Twitter Mailbag: Gilead, Chelsea, Keryx, Onyx, BioSante, Dendreon

Biotech Twitter Mailbag: Gilead, Chelsea, Keryx, Onyx, BioSante, Dendreon

Biotech columnist Adam Feuerstein responds to biotech stock questions posed by his Twitter followers.

Dendreon Announces Executive Appointments

Dendreon Announces Executive Appointments

February 28, 2012--Dendreon Corporation (Nasdaq:DNDN) today announced three new appointments to the Company’s executive team.

Dendreon's CEO Discusses Q4 2011 Results - Earnings Conference Call

Dendreon's CEO Discusses Q4 2011 Results - Earnings Conference Call

Dendreon's CEO Discusses Q4 2011 Results - Earnings Conference Call

Dendreon Stock Falls On Unusually High Volume (DNDN)

Dendreon Stock Falls On Unusually High Volume (DNDN)

Dendreon (Nasdaq:DNDN) is trading at unusually high volume Monday with 35.6 million shares changing hands. It is currently at four times its average daily volume and trading down $3.02 (-20.3%).

Dendreon Reports Fourth Quarter And 2011 Year End Financial Results

Dendreon Reports Fourth Quarter And 2011 Year End Financial Results

February 27, 2012--Dendreon Corporation (Nasdaq: DNDN) today reported results for the year and quarter ended December 31, 2011.

Dendreon Announces New Time For Fourth Quarter And Year-End Financial Results Conference Call And Webcast Presentations At Upcoming Conferences

Dendreon Announces New Time For Fourth Quarter And Year-End Financial Results Conference Call And Webcast Presentations At Upcoming Conferences

February 22, 2012 – Dendreon Corporation (Nasdaq: DNDN) today announced that management will host a conference call on Monday, February 27, 2012, at 9:00 a.

Will Greece Indigestion Take Down Markets?

Will Greece Indigestion Take Down Markets?

Alix Steel and Scott Redler, chief strategic officer at T3Live.com, reveal how to trade stocks on Tuesday's news.

Off the Charts

Off the Charts

Continue to maneuver this action and take trades when they become apparent.

7 Relative Strength Stocks to Beat the Market

7 Relative Strength Stocks to Beat the Market

Relative strength is one of the best tools we have to identify stocks that are likely to beat the market in 2012.

Dendreon To Host Conference Call On February 27 To Announce Fourth Quarter And Year-End Financial Results And Webcast Presentations At Upcoming Conferences

Dendreon To Host Conference Call On February 27 To Announce Fourth Quarter And Year-End Financial Results And Webcast Presentations At Upcoming Conferences

February 1, 2012 – Dendreon Corporation (Nasdaq: DNDN) today announced that management will host a conference call on Monday, February 27, 2012, at 4:30 p.

8 Stocks Rising on Huge Volume

8 Stocks Rising on Huge Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

Dendreon Announces CEO And Chairman Succession Plan

Dendreon Announces CEO And Chairman Succession Plan

February 1, 2012 – Dendreon Corporation (Nasdaq: DNDN) today announced that its Board of Directors has elected John H.

Dendreon Announces Presentation Of PROVENGE Data At The ASCO 2012 Genitourinary Cancers Symposium

Dendreon Announces Presentation Of PROVENGE Data At The ASCO 2012 Genitourinary Cancers Symposium

January 31, 2012 – Dendreon Corporation (NASDAQ: DNDN) today announced the following PROVENGE ® data will be presented at the American Society of Clinical Oncology 2012 Genitourinary Cancers Symposium...

Medivation's Prostate Cancer Drug: Survival Benefit With Low Seizure Risk

Medivation's Prostate Cancer Drug: Survival Benefit With Low Seizure Risk

Medivation's MDV3100 significantly prolonged survival in prostate cancer patients and seizures -- an investor concern -- doesn't appear to be a problem.

Analysts' Actions: BHI, MCD, MRO, KMB

Analysts' Actions: BHI, MCD, MRO, KMB

Here are today's top research calls.

Find Buying Opportunities as Markets Consolidate

Find Buying Opportunities as Markets Consolidate

Alix Steel and Scott Redler, chief strategic officer at T3Live.com, reveal how to trade stocks ahead of earnings season: retail, banks, tech.

Daily Recap of the Charts Jan. 24

Daily Recap of the Charts Jan. 24

Scott Redler of T3Live reviews the day's market action and sets up your trading plan for the next session.

Off the Charts

Off the Charts

The uptrend remains intact.

Aastrom CEO: Financing Close to Completion

Aastrom CEO: Financing Close to Completion

Raising $30 million this quarter will full fund Aastrom's phase III study of its cellular therapy for patients with blocked leg arteries.

Dendreon's Management Presents At J.P. Morgan Healthcare Conference (Transcript)

Dendreon's Management Presents At J.P. Morgan Healthcare Conference (Transcript)

Dendreon's Management Presents at J.P. Morgan Healthcare Conference (Transcript)

J.P. Morgan Biotech Confab Live Chat

J.P. Morgan Biotech Confab Live Chat

TheStreet's Adam Feuerstein will give his impressions of the J.P. Morgan Healthcare Conference and answer readers' biotech investing questions.

6 Stocks Rising on Huge Volume

6 Stocks Rising on Huge Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.